Literature DB >> 2544842

Congenital hypertrophy of the retinal pigment epithelium in familial adenomatous polyposis.

A Romania1, Z N Zakov, E McGannon, T Schroeder, F Heyen, D G Jagelman.   

Abstract

One hundred fifty-three members of 56 kindreds with familial adenomatous polyposis (FAP) underwent funduscopic examination for congenital hypertrophy of the retinal pigment epithelium (CHRPE). All patients underwent wide-angle fundus photography to document lesions, proctosigmoidoscopy to document polyps, and examination for extracolonic manifestations. Ninety-seven patients were diagnosed as having FAP and 56 patients were offspring of FAP patients and thus at 50% risk of inheriting the disease. In two thirds of the kindreds, CHRPE could be used as a congenital phenotypic marker to predict the presence or development of polyps. In these kindreds, all patients with diagnosed FAP and 39% of the patients at risk had at least four CHRPE lesions. In one third of the kindreds, CHRPE could not be used as a predictive congenital marker, and in these kindreds all patients had zero to three total lesions of CHRPE. The presence of CHRPE did not correlate with any other extracolonic manifestations. In kindreds without any other extracolonic manifestations, CHRPE can still be present and can be used as a predictive congenital phenotypic marker.

Entities:  

Mesh:

Year:  1989        PMID: 2544842     DOI: 10.1016/s0161-6420(89)32822-3

Source DB:  PubMed          Journal:  Ophthalmology        ISSN: 0161-6420            Impact factor:   12.079


  15 in total

1.  Familial adenomatous polyposis in China.

Authors:  Jun Yang; Qing Wei Liu; Liang Wen Li; Qiang Zhi Wang; Min Hong; Jian Dong
Journal:  Oncol Lett       Date:  2016-10-31       Impact factor: 2.967

Review 2.  Congenital focal abnormalities of the retina and retinal pigment epithelium.

Authors:  Yingna Liu; Anthony T Moore
Journal:  Eye (Lond)       Date:  2020-05-04       Impact factor: 3.775

3.  Fluorescein angiographic features of the congenital hypertrophy of the retinal pigment epithelium in the familial adenomatous polyposis.

Authors:  Rosario Touriño; M Teresa Rodríguez-Ares; M J López-Valladares; Francisco Gómez-Ulla; Manuel Gómez-Torreiro; Carmen Capeans
Journal:  Int Ophthalmol       Date:  2006-06-15       Impact factor: 2.031

4.  Genetic heterogeneity of congenital hypertrophy of the retinal pigment epithelium (CHRPE) in families with familial adenomatous polyposis.

Authors:  S V Hodgson; D T Bishop; B Jay
Journal:  J Med Genet       Date:  1994-01       Impact factor: 6.318

Review 5.  Familial adenomatous polyposis: The practical applications of clinical and molecular screening.

Authors:  Paul Rozen; Finlay Macrae
Journal:  Fam Cancer       Date:  2006       Impact factor: 2.375

6.  Value of the congenital hypertrophy of the retinal pigment epithelium in the diagnosis of familial adenomatous polyposis.

Authors:  Rosario Touriño; Rogelio Conde-Freire; José M Cabezas-Agrícola; Teresa Rodríguez-Aves; Maria Jesús López-Valladares; José L Otero-Cepeda; Carmen Capeans
Journal:  Int Ophthalmol       Date:  2004-03       Impact factor: 2.031

7.  Value of combined phenotypic markers in identifying inheritance of familial adenomatous polyposis.

Authors:  F M Giardiello; G J Offerhaus; E I Traboulsi; J C Graybeal; I H Maumenee; A J Krush; L S Levin; S V Booker; S R Hamilton
Journal:  Gut       Date:  1991-10       Impact factor: 23.059

8.  The UK Northern region genetic register for familial adenomatous polyposis coli: use of age of onset, congenital hypertrophy of the retinal pigment epithelium, and DNA markers in risk calculations.

Authors:  J Burn; P Chapman; J Delhanty; C Wood; F Lalloo; M B Cachon-Gonzalez; K Tsioupra; W Church; M Rhodes; A Gunn
Journal:  J Med Genet       Date:  1991-05       Impact factor: 6.318

Review 9.  Familial Adenomatous Polyposis.

Authors:  Alexia Waller; Sarah Findeis; Michael J Lee
Journal:  J Pediatr Genet       Date:  2016-03-15

10.  Changes in the retinal pigment epithelium close to retinal vessels in familial adenomatous polyposis.

Authors:  D Schmidt; C E Jung; G Wolff
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-02       Impact factor: 3.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.